Effects of lesions of the Substantia Innominata/Ventral Pallidum, Globus Pallidus and Medial Septum on rat's performance in object-recognition and radial-maze tasks: Physostigmine and amphetamine treatments

Pharmacological Research

Volumn 38, Issue 4, 1998, Pages 251-263

  Ennaceur, Abdelkader ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Amphetamine; Globus pallidus; Learning; Medial septum; Memory; Meynert; Nucleus basalis magnocellularis; Physostigmine; Rats

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; NOOTROPIC AGENT; PHYSOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; GLOBUS PALLIDUS; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; LEARNING TEST; MALE; MAZE TEST; MEMORY; NONHUMAN; PEDUNCULAR ANSA; PRIORITY JOURNAL; RAT; RECOGNITION; SEPTUM PELLUCIDUM; SPATIAL MEMORY; TASK PERFORMANCE;

EID: 0032189944     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0361     Document Type: Article

References (85)

1. 1. Bartus RT, Dean LL, Beer B, Lippa A. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-17.
2. 2. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 1986; 19: 1-28.
3. 3. Davies P, Verth AH. Regional distribution of muscarnic acetylcholine receptor in normal and Alzheimer's-type dementia brains. Brain Res 1978; 138: 385-92.
4. 4. Kopelman MD. The cholinergic neurotransmitter system in human memory and dementia: a review. Q J Exp Psychol 1986; 38A: 535-73.
5. 5. Beninger RJ, Wirsching BA, Jhamandas K, Boegman RJ. Animal studies of brain acetylcholine and memory. Arch Gerontol Geriatr Suppl 1989; 1: 71-90.
6. 6. Decker MW. The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res Rev 1987; 12: 423-38.
7. 7. Gallagher M, Colombo PJ. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 1995; 5: 161-8.
8. 8. Kesner RP. Reevaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiol Aging 1988; 9: 609-16.
9. 9. Olton DS, Wenk GL. Dementia: Animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system. In: Psychopharmacology: The third generation of Progress. Meltzer HY, ed. New York: Raven Press, 1987: pp. 941-53.
10. 10. Riekkinen P Jr, Sirvio J, Riekkinen P. Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non specific subcortical cell loss. Behav Brain Res 1990; 37: 81-8.
11. 11. Mesulam M-M. Central cholinergic pathways: Neuroanatomy and some behavioral implications. In: Neurotransmitters and cortical function. Avoli M, Reader TA, Dykes RW, Gloor P. eds. Plenum Publishing Corp, 1988: pp. 237-60.
12. 12. Aigner TG, Mishkin M. The effects of physostigmine and scopolamine on recognition memory in monkeys. Behav Neural Biol 1986; 45: 81-7.
13. 13. Delwaide PJ, Devoitille JM, Ylieff M. Acute effect of drugs upon memory of patients with senile dementia. Acta Psychiatr Belg 1980; 80: 748-54.
14. 14. Drachman DA, Leavitt J. Human memory and the cholinergic system: a relationship to ageing? Arch Neurol 1974; 30: 113-21.
15. 15. Ghoneim MM, Mewaldt SP. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine. Psychopharmacology 1977; 52: 1-6.
16. 16. Rusted JM, Warburton DM. The effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology 1988; 96: 145-52.
17. 17. Dawson GR, Heyes CM, Iversen SD. Pharmacological mechanisms and animal models of cognition. Behav Pharmacol 1992; 3: 285-97.
18. 18. Fibiger HC. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. TINS 1991; 6: 220-3.
19. 19. Muir JL, Dunnett SB, Robbins TW, Everitt BJ. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice reaction time task. Exp Brain Res 1992; 89: 611-22.
20. 20. Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG. Behavioral, biochemical, histological, and electrophysiological effects of 192-IgG-Saporin injections into the basal forebrain of rats. J Neurosci 1994; 14: 5986-95.
21. 21. Olton DS, Samuelson RJ. Remembrance of places passed: spatial memory in rat. J Exp Psychol: Anim Behav Proc 1976; 2: 97-116.
22. 22. Ennaceur A, Meliani K. A new one-trial test for neurobiological studies of memory in rats. III: Spatial vs. non spatial working memory. Behav Brain Res 1992; 51: 83-92.
23. 23. Ennaceur A, Aggleton JP. Spontaneous recognition of object configurations in rats: Effect of lesions of the fornix. Exp Brain Res 1994; 100: 85-92.
24. 24. Ennaceur A, Neave N, Aggleton JP. Spontaneous object recognition and object location in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res 1997; 113: 509-19.
25. 25. Dunnett SB. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats. Psychopharmacology 1985; 87: 357-63.
26. 26. Dunnett SB, Rogers DC, Jones GH. Effects of nucleus basalis magnocellularis lesions in rat on delayed matching and non-matching to position tasks. Eur J Neurosci 1989; 4: 395-406.
27. 27. Etherington R, Mittleman G, Robbins TW. Comparative effects of nucleus basalis and fimbria-fornix lesions on delayed matching and alternation tests of memory. Neurosci Res Comm 1987; 1: 135-43.
28. 28. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic acid lesion of the nucleus basalis of Meynert. Psychopharmacology 1987; 92: 292-300.
29. 29. Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Petigrew KD, Mishkin M. Transient impairment of recognition memory following ibotenic acid lesions of the basal forebrain in macaques. Exp Brain Res 1991; 86:18-26.
30. 30. Bartolini L, Casamenti F, Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 1996; 53: 277-83.
31. 31. Santucci AC, Haroutunian V. Nucleus basalis-lesions impair memory in rats trained on nonspatial and spatial discrimination task. Physiol Behav 1989; 45: 1025-31.
32. 32. Voytko ML. Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention. Behav Brain Res 1996; 75: 13-25.
33. 33. Robbins TW, Everitt BJ, Marston HM, Wilkinson J, Jones GH, Page KJ. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav Brain Res 1989; 35: 221-40.
34. 34. Roberts AC, Robbins TW, Everitt BJ, Muir JL. A specific form of cognitive rigidity following excitotoxic lesions of the basal forebrain in marmosets. Neuroscience 1992; 47: 251-64.
35. 35. Ennaceur A, Meliani K. Effects of physostigmine and scopolamine on rats' performances in object recognition and radial-maze tests. Psychopharmacology 1992; 109: 321-30.
36. 36. Deutsch JA, Rogers JB. Brain acetylcholine and neuropsychiatric disease, In: Davis KL, Berger PA. eds. New York: Plenum, 1979, p. 175ff.
37. 37. Ennaceur A. Effects of amphetamine and medial septal lesions on acquisition and retention of radialmaze learning in rats. Brain Res 1994; 636: 277-85.
38. 38. Beatty WW, Bierly RA, Boyd J. Amphetamine disrupts both working and reference memories of rats trained in a radial maze. Behav Neural Biol 1984; 42: 169-76.
39. 39. Beatty WW, Rush JR. Retention deficits after D-amphetamine treatment: memory defect or performance change? Behav Neural Biol 1983; 37: 265-75.
40. 40. Buresova O, Bures J. Radial maze as a tool for assessing the effects of drugs on the working memory of rats. Psychopharmacology 1982; 77: 268-71.
41. 41. Cassell JC, Kelche C, Dalrymple-Alford JC, Will B. Effects of physostigmine and D-amphetamine on the behavior of rats with selective fimbria-fornix lesions and intrahippocampal fetal septal cell transplants. Behav Neurosci 1988; 50: 229-39.
42. 42. Packard MG, White NM. Memory facilitation produced by dopamine agonists: role of receptor subtype and mnemonic requirements. Pharmacol Biochem Behav 1989; 33: 511-18.
43. 43. Packard MG, Williams CL, McGaugh JL. Enhancement of win-shift radial maze retention by peripheral posttraining administration of D-amphetamine and 4-OH amphetamine. Psychobiology 1992; 20: 280-5.
44. 44. Strupp BJ, Bunsey M, Levitsky D, Kesler M. Time dependent effects of post-trial amphetamine treatments in rats: evidence for enhanced storage of representational memory. Behav Neural Biol 1991; 56: 62-76.
45. 45. Mumby DG, Wood ER, Duva CA, Kornecook TJ, Pinel JPJ, Phillips AG. Ischemia-induced object-recognition deficits in rats are attenuated by hippocampal ablation before or soon after ischemia. Behav Neurosci 1996; 110: 266-81.
46. 46. Dunnett SB, Everitt SB, Robbins TW. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. TINS 1991; 14: 494-501.
47. 47. Bannon AW, Curzon P, Gunther KL, Decker MW. Effects of intraseptal injection of 192-IGg-saporin in mature and aged Long-Evans rats. Brain Res 1996; 718: 25-36.
48. 48. Berger-Sweeney J, Heckers S, Mesulam MM, Wiley RG, Lappi DA, Sharma M. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J Neurosci 1994; 14: 4507-19.
49. 49. Torres EM, Perry TA, Blokland A, Wilkinson LS, Wiley RG, Lappi DA, Dunnett SB. Behavioral, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 1994; 63: 95-122.
50. 50. Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thai LJ. 192-Immunoglobulin G-Saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar purkinje cells. Neuroscience 1995; 65: 463-76.
51. 51. Paxinos G, Watson C. The rat brain in stereotaxic co-ordinates. New York: Academic Press, 1982.
52. 52. Winer BJ. Statistical Principles In Experimental Design. 2nd ed. Tokyo: McGraw-Hill, 1971.
53. 53. Hepler DJ, Olton DS, Wenk GL, Coyle JT. Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. Neuroscience 1985; 5: 866-73.
54. 54. Wozniak DF, Stewart GR, Finger S, Olney JW. Comparison of behavioral effects of nucleus basalis magnocellularis lesions and somatosensory cortex ablation in the rat. Neuroscience 1989; 32: 685-700.
55. 55. Everitt BJ, Robbins TW, Evenden JL, Marston HM, Jones GH, Sirkia TE. The effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on the acquisition and retention of a conditional visual discrimination: implications for cholinergic hypotheses of learning and memory. Neuroscience 1987; 22: 441-69.
56. 56. Evenden JL, Marston HM, Jones GH, Giardini V, Lenard L, Everitt BJ, Robbins TW. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat. Behav Brain Res 1989; 32: 129-49.
57. 57. Flicker C, Dean RL, Watkins DL, Fisher SK, Bartus RT. Behavioral and neurochemical effects following neurotoxic lesions of a major input to the cerebral cortex in the rat. Pharmacol Biochem Behav 1983; 18: 973-81.
58. 58. Robbins TW, Everitt BJ, Ryan CN, Marston HM, Jones GH, Page KJ. Comparative effects of quisqualic and ibotenic acid-induced lesions of the substantia innominata and globus pallidus on the acquisition of a conditional visual discrimination: differential effects on cholinergic mechanisms. Neuroscience 1989; 28: 337-52.
59. 59. Dubois B, Mayo W, Agid Y, LeMoal M, Simon H. Profound disturbances of spontaneous and learned behaviours following lesions of the nucleus basalis magnocellularis in the rat. Brain Res 1985; 338: 249-58.
60. 60. Murray CL, Fibiger HC. Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Neuroscience 1986; 14: 1025-32.
61. 61. Lo Conte G, Bartolini L, Casamenti F, Marconcini-Pepeu I, Pepeu G. Lesions of cholinergic forebrain nuclei: changes in avoidance behavior and scopolamine actions. Pharmacol Biochem Behav 1982; 17: 933-7.
62. 62. Salamone JD, Beart PM, Alpert JE, Iversen SD. Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats. Behav Brain Res 1984; 13: 63-70.
63. 63. Abdulla FA, Calaminici M-R, Stephenson JD, Sinden JD. Unilateral AMPA lesions of nucleus basalis magnocellularis induce a sensorimotor deficit which is differentially altered by arecoline and nicotine. Behav Brain Res 1994; 60: 161-9.
64. 64. Austin MC, Kalivas PW. Dopaminergic involvement in locomotion elicited from the ventral pallidum/ substantia innominata. Brain Res 1991; 542: 123-31.
65. 65. Cromwell HC, Berridge KC. Mapping of globus pallidus and ventral pallidum lesions that produce hyperkinetic treading. Brain Res 1994; 668: 16-29.
66. 66. Napier TC, Chrobak JJ. Evaluations of ventral pallidal dopamine receptor activation in behaving rats. NeuroReport 1992; 3: 609-11.
67. 67. Ennaceur A, Aggleton JP, Fray P, Cooper SJ. Delayed-non-match-to-sample (DNMS) tasks: methodological considerations. Behav Pharmacol 1996; 7: 34-5.
68. 68. Ennaceur A, Aggleton JP, Fray PJ. Delayed non-matching to sample in a novel automated visual memory apparatus using mixed retention intervals. Neurosci Res Comm 1997; 20: 103-11.
69. 69. Ennaceur A, Aggleton JP. The role of contiguity between stimulus, response and reinforcement and the effect of the presence of a cue on rat's performance in a delayed non matching to position task assessed in a novel automated visual memory apparatus. Neurosci Res Comm 1998; 22: 21-9.
70. 70. Sutherland RJ, Rudy JW. Configurai association theory: the role of the hippocampal formation in learning, memory and amnesia. Psychobiology 1989; 17: 129-44.
71. 71. O'Keefe J, Nadel L. The hippocampus as a cognitive map. Oxford: Clarendon Press, 1978.
72. 72. Miller RE, Murphy JV. Influence of the spatial relationships between the cue, reward, and response in discrimination learning. J Exp Psychol 1964; 67: 120-3.
73. 73. Beninger RJ, Wirsching BA, Mallet PE, Jhamandas K, Boegman RJ. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory impaired rats. Pharmacol Biochem Behav 1995; 51: 739-46.
74. 74. Cho YH, Jaffard R. Spatial location learning in mice with ibotenate lesions of entorhinal cortex or subiculum. Neurobiol Learning Memory 1995; 64: 285-90.
75. 75. Turner JJ, Hodges H, Sinden JD, Gray JA. Comparison of radial maze performance of rats after ibotenate and quisqualate lesions of the forebrain cholinergic projection system: effects of pharmacological challenge and changes in training regime. Behav Pharmacol 1992; 3: 359-73.
76. 76. Ennaceur A. The construct validity of animal models of memory and amnesia. Int Behav Neurosci Soc Abstr 1995; 4: 53.
77. 77. Sarter M, Hagan J, Dudchenko P. Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I. Psychopharmacology 1992; 107: 144-59.
78. 78. Ennaceur A, Monmaur P, Ennaceur SM, Puma C, Sharif A. Taking into account the changes that follow the degeneration of neurons in the brain. J Psychopharmacol 1995; 9: A27.
79. 79. Inglis FM, Fibiger HC. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience 1995; 66: 81-6.
80. 80. Riekkinen P, Soininen H, Helkala E-L, Partanen K, Laasko M, Vanhanen M, Riekkinen P. Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease. NeuroReport 1995; 6: 1297-300.
81. 81. Ferraridileo G, Mash DC, Flynn DD. Attenuation of muscarnic receptor-G-protein interaction in Alzheimer-disease. Molec Chem Neuropathol 1995; 24: 69-91.
82. 82. Flynn DD, Weinstein DA, Mash DC. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann Neurol 1991; 29: 256-62.
83. 83. Thorne B, Potter PE. Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function. Brain Res Bull 1995; 38: 121-7.
84. 84. Rossner S, Schliebs R, Bigl V. Ibotenic acid lesions of the nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and gabaergic markers in cortical rat-brain regions. Brain Res 1994; 668: 85-99.
85. 85. Rossner S, Schliebs R, Bigl V. 192IgG-Saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affects glutamatergic and gabaergic markers in cortical rat-brain regions. Brain Res 1995; 696: 165-76.